CLYM 8-K 2026-10-23

Climb Bio, Inc. (CLYM) 8-K dated 2026-10-23 — accession 0001193125-26-430681. This URL is the filing, not the CLYM hub.

Climb Bio, Inc. (CLYM) is a biotechnology company listed on US.

Climb Bio, Inc. filed a 8-K on 2026-10-23. Accession 0001193125-26-430681.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CLYM revenue for 2024-12-31 was $8.1M. Net income was -$73.9M. Revenue was up 76.0% from 2023-12-31 to 2024-12-31. CLYM currently screens at market cap $85.8M.

Not investment advice. The CLYM SEC hub lists recent forms. The stock page is the research view.